Although definitions of gain-of-function differ, investigative reports leave no question researchers manipulated ...

On the eve of Donald Trump's inauguration, the US Department of Health banned the financing and activities of the EcoHealth ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

CAR-T cell therapy achieves 18-year survival milestone in cancer patient Innovative cancer treatment shows promise as ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in ... therapies, chimeric antigen receptor T-cell (CAR-T) therapies, and Janus kinase ...

The presence of these chimeric viruses underscores the intricate relationships between different viral families and their evolutionary trajectories. Additionally, studies have explored the origins ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...